CRA’s Lev Gerlovin and co-authors Walter Colasante and Pascale Diesel published a series of three articles in Cell & Gene on emerging gene and cell therapies and their impact on the market.
Read the full series below:
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s Lev Gerlovin and co-authors Walter Colasante and Pascale Diesel published a series of three articles in Cell & Gene on emerging gene and cell therapies and their impact on the market.
Read the full series below:
European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain, bringing together the global oncology community to share the latest...
The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program (MDPNP) directs the Secretary of Health and Human Services (HHS) to set a maximum...
CRA is a proud sponsor of the event honoring Pulitzer prize-winning journalist, Andrea Elliott, author of Invisible Child: Poverty, Survival, and Hope in an...
CRA is a proud sponsor of the event supporting the not-for-profit public interest foundation whose mission is promoting public discourse on the proper role of...